Threshold Pharmaceuticals Inc

Premium Company Profile

Publication Date	March 2008
Publisher	Datamonitor
Product Type	Databook
Pages	45
ISBN Number	not applicable
Product Code	DAT10941

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

Threshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of drugs based on metabolic targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells. The company uses metabolic targeting technology to identify new product candidates, therapeutic indications and technologies.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Threshold Pharmaceuticals's lead candidate is glufosfamide which is being developed as second line treatment for metastatic pancreatic cancer (Phase III), platinum resistant ovarian cancer (Phase II), soft tissue sarcoma (Phase II); and small cell lung cancer (Phase II). The company derives its entire revenues from a collaboration agreement with MediBIC for the development of glufosfamide for the treatment of pancreatic cancer in certain Asian countries, including Japan, South Korea, India, China, Taiwan and Hong Kong. Threshold Pharmaceuticals is expected to witness an absolute decline of -$1 million during the forecast period 2006-2010. This would be driven by the failure of glufosfamide in meeting the primary endpoint in the Phase III trial in patients with metastatic pancreatic cancer who had relapsed after gemcitabine chemotherapy.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization.

Content

Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Pipeline Products
Ac Forecast Product Sales
Competitors and Strategic Business Relationships
Top Competitors
Key Suppliers
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Threshold Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Tables
- Table 1: Threshold Pharmaceuticals - Key Facts
- Table 2: Threshold Pharmaceuticals - Other Locations and Subsidiaries
- Table 3: Threshold Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: Threshold Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: Threshold Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Threshold Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: Threshold Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Threshold Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Threshold Pharmaceuticals - in-house Pipeline Products
- Table 10: Threshold Pharmaceuticals - Collaboration Pipeline Products
- Table 11: Threshold Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 12: Threshold Pharmaceuticals - Top Competitors
- Table 13: Threshold Pharmaceuticals - Key Suppliers
- Table 14: Threshold Pharmaceuticals - Key Shareholders
- Table 15: Threshold Pharmaceuticals - SWOT Analysis Summary
- Table 16: Threshold Pharmaceuticals - Value Chain Analysis
- Table 17: Threshold Pharmaceuticals - Scorecard
- Table 18: Threshold Pharmaceuticals - Key Employees
- Table 19: Threshold Pharmaceuticals - Financial and Operational Overview